Huicong Niu

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 6

Top Topics

Advanced Non Small Cell Lung Cancer

Epidermal Growth Factor Receptor

Ejection Fraction

Cerebral Ischemia

Top Venues

Molecular cancer research : MCR

Journal of the American Heart Association

This page only lists publications with an associated author ORCID identifier.

Publications

Jie Jin, Yumeng Cui, Huicong Niu, Yanli Lin, Xiaojie Wu, Xuejiao Qi, Kaixuan Bai, Yu Zhang, Youliang Wang, Hui Bu
NSCLC extracellular vesicles containing miR-374a-5p promote leptomeningeal metastasis by influencing blood‒brain barrier permeability. Molecular cancer research : MCR (2024)
Jie Jin, Yumeng Cui, Huicong Niu, Yanli Lin, Xiaojie Wu, Xuejiao Qi, Kaixuan Bai, Yu Zhang, Youliang Wang, Hui Bu
NSCLC Extracellular Vesicles Containing miR-374a-5p Promote Leptomeningeal Metastasis by Influencing Blood‒Brain Barrier Permeability. Molecular cancer research : MCR 22 (8) (2024)
Jie Jin, Yumeng Cui, Huicong Niu, Yanli Lin, Xiaojie Wu, Xuejiao Qi, Kaixuan Bai, Yu Zhang, Youliang Wang, Hui Bu
NSCLC Extracellular Vesicles Containing miR-374a-5p Promote Leptomeningeal Metastasis by Influencing Blood‒Brain Barrier Permeability. Molecular cancer research : MCR 22 (8) (2024)
Jie Jin, Yumeng Cui, Huicong Niu, Yanli Lin, Xiaojie Wu, Xuejiao Qi, Kaixuan Bai, Yu Zhang, Youliang Wang, Hui Bu
NSCLC Extracellular Vesicles Containing miR-374a-5p Promote Leptomeningeal Metastasis by Influencing Blood‒Brain Barrier Permeability. Molecular cancer research : MCR 22 (8) (2024)
Jie Jin, Yumeng Cui, Huicong Niu, Yanli Lin, Xiaojie Wu, Xuejiao Qi, Kaixuan Bai, Yu Zhang, Youliang Wang, Hui Bu
NSCLC Extracellular Vesicles Containing miR-374a-5p Promote Leptomeningeal Metastasis by Influencing Blood‒Brain Barrier Permeability. Molecular cancer research : MCR 22 (8) (2024)
Mengyao Shi, Jin Zheng, Yang Liu, Xueyu Mao, Xuechun Wu, Min Chu, Huicong Niu, Lulu Sun, Xinyue Chang, Yu He, Yi Liu, Daoxia Guo, Yonghong Zhang, Zhengbao Zhu, Jing Zhao
Folate, Homocysteine, and Adverse Outcomes After Ischemic Stroke. Journal of the American Heart Association (2024)